SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model

G. Kim, M. Ouzounova, A. A. Quraishi, A. Davis, N. Tawakkol, S. G. Clouthier, F. Malik, A. K. Paulson, R. C. D'Angelo, S. Korkaya, T. L. Baker, E. S. Esen, A. Prat, S. Liu, C. G. Kleer, D. G. Thomas, M. S. Wicha, Hasan Korkaya

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Somatic mutations or deletions of TP53 and PTEN in ductal carcinoma in situ lesions have been implicated in progression to invasive ductal carcinomas. A recent molecular and mutational analysis of breast cancers revealed that inactivation of tumor suppressors, p53 and PTEN, are strongly associated with triple negative breast cancer. In addition, these tumor suppressors have important roles in regulating self-renewal in normal and malignant stem cells. To investigate their role in breast carcinogenesis, we knocked down these genes in human mammary cells and in non-transformed MCF10A cells. p53 and PTEN knockdown synergized to activate pro-inflammatory interleukin-6 (IL6)/Stat3/nuclear factor κB signaling. This resulted in generation of highly metastatic epithelial-to-mesenchymal transition-like cancer stem cells resulting in tumors whose gene expression profile mimicked that found in basal/claudin-low molecular subtype within the triple negative breast tumors. Constitutive activation of this loop in transformed cells was dependent on proteolytic degradation of suppressor of cytokine signaling 3 (SOCS3) resulting in low levels of this protein in basal/claudin-low cell lines and primary tumors. In non-transformed cells, transient activation of the IL6 inflammatory loop induced SOCS3 expression leading to pathway inactivation. In transformed cells, enforced expression of SOCS3 or interfering with IL6 pathway via IL6R blockade inhibited tumor growth and metastasis in mouse xenograft models. Furthermore, circulating tumor cells were significantly reduced in tumor-bearing animals when treated with anti-IL6R antibodies. These studies uncover important connections between inflammation and carcinogenesis and suggest that blocking pro-inflammatory cytokines may be utilized as an attractive strategy to target triple negative breast tumors, which currently lacks molecularly targeted therapies.

Original languageEnglish (US)
Pages (from-to)671-680
Number of pages10
JournalOncogene
Volume34
Issue number6
DOIs
StatePublished - Feb 5 2015

Fingerprint

Triple Negative Breast Neoplasms
Cytokines
Neoplasms
Breast Neoplasms
Interleukin-6
Carcinogenesis
Breast
CCAAT-Enhancer-Binding Protein-beta
Circulating Neoplastic Cells
Ductal Carcinoma
Carcinoma, Intraductal, Noninfiltrating
Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Sequence Deletion
Tumor Cell Line
Transcriptome
Heterografts
Anti-Idiotypic Antibodies
Stem Cells
Neoplasm Metastasis

Keywords

  • IL6
  • PTEN
  • breast cancer
  • inflammatory cytokine
  • p53
  • triple negative subtype

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. / Kim, G.; Ouzounova, M.; Quraishi, A. A.; Davis, A.; Tawakkol, N.; Clouthier, S. G.; Malik, F.; Paulson, A. K.; D'Angelo, R. C.; Korkaya, S.; Baker, T. L.; Esen, E. S.; Prat, A.; Liu, S.; Kleer, C. G.; Thomas, D. G.; Wicha, M. S.; Korkaya, Hasan.

In: Oncogene, Vol. 34, No. 6, 05.02.2015, p. 671-680.

Research output: Contribution to journalArticle

Kim, G, Ouzounova, M, Quraishi, AA, Davis, A, Tawakkol, N, Clouthier, SG, Malik, F, Paulson, AK, D'Angelo, RC, Korkaya, S, Baker, TL, Esen, ES, Prat, A, Liu, S, Kleer, CG, Thomas, DG, Wicha, MS & Korkaya, H 2015, 'SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model', Oncogene, vol. 34, no. 6, pp. 671-680. https://doi.org/10.1038/onc.2014.4
Kim, G. ; Ouzounova, M. ; Quraishi, A. A. ; Davis, A. ; Tawakkol, N. ; Clouthier, S. G. ; Malik, F. ; Paulson, A. K. ; D'Angelo, R. C. ; Korkaya, S. ; Baker, T. L. ; Esen, E. S. ; Prat, A. ; Liu, S. ; Kleer, C. G. ; Thomas, D. G. ; Wicha, M. S. ; Korkaya, Hasan. / SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. In: Oncogene. 2015 ; Vol. 34, No. 6. pp. 671-680.
@article{ae89b1b70f35453194f38ab1713ecd3b,
title = "SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model",
abstract = "Somatic mutations or deletions of TP53 and PTEN in ductal carcinoma in situ lesions have been implicated in progression to invasive ductal carcinomas. A recent molecular and mutational analysis of breast cancers revealed that inactivation of tumor suppressors, p53 and PTEN, are strongly associated with triple negative breast cancer. In addition, these tumor suppressors have important roles in regulating self-renewal in normal and malignant stem cells. To investigate their role in breast carcinogenesis, we knocked down these genes in human mammary cells and in non-transformed MCF10A cells. p53 and PTEN knockdown synergized to activate pro-inflammatory interleukin-6 (IL6)/Stat3/nuclear factor κB signaling. This resulted in generation of highly metastatic epithelial-to-mesenchymal transition-like cancer stem cells resulting in tumors whose gene expression profile mimicked that found in basal/claudin-low molecular subtype within the triple negative breast tumors. Constitutive activation of this loop in transformed cells was dependent on proteolytic degradation of suppressor of cytokine signaling 3 (SOCS3) resulting in low levels of this protein in basal/claudin-low cell lines and primary tumors. In non-transformed cells, transient activation of the IL6 inflammatory loop induced SOCS3 expression leading to pathway inactivation. In transformed cells, enforced expression of SOCS3 or interfering with IL6 pathway via IL6R blockade inhibited tumor growth and metastasis in mouse xenograft models. Furthermore, circulating tumor cells were significantly reduced in tumor-bearing animals when treated with anti-IL6R antibodies. These studies uncover important connections between inflammation and carcinogenesis and suggest that blocking pro-inflammatory cytokines may be utilized as an attractive strategy to target triple negative breast tumors, which currently lacks molecularly targeted therapies.",
keywords = "IL6, PTEN, breast cancer, inflammatory cytokine, p53, triple negative subtype",
author = "G. Kim and M. Ouzounova and Quraishi, {A. A.} and A. Davis and N. Tawakkol and Clouthier, {S. G.} and F. Malik and Paulson, {A. K.} and D'Angelo, {R. C.} and S. Korkaya and Baker, {T. L.} and Esen, {E. S.} and A. Prat and S. Liu and Kleer, {C. G.} and Thomas, {D. G.} and Wicha, {M. S.} and Hasan Korkaya",
year = "2015",
month = "2",
day = "5",
doi = "10.1038/onc.2014.4",
language = "English (US)",
volume = "34",
pages = "671--680",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model

AU - Kim, G.

AU - Ouzounova, M.

AU - Quraishi, A. A.

AU - Davis, A.

AU - Tawakkol, N.

AU - Clouthier, S. G.

AU - Malik, F.

AU - Paulson, A. K.

AU - D'Angelo, R. C.

AU - Korkaya, S.

AU - Baker, T. L.

AU - Esen, E. S.

AU - Prat, A.

AU - Liu, S.

AU - Kleer, C. G.

AU - Thomas, D. G.

AU - Wicha, M. S.

AU - Korkaya, Hasan

PY - 2015/2/5

Y1 - 2015/2/5

N2 - Somatic mutations or deletions of TP53 and PTEN in ductal carcinoma in situ lesions have been implicated in progression to invasive ductal carcinomas. A recent molecular and mutational analysis of breast cancers revealed that inactivation of tumor suppressors, p53 and PTEN, are strongly associated with triple negative breast cancer. In addition, these tumor suppressors have important roles in regulating self-renewal in normal and malignant stem cells. To investigate their role in breast carcinogenesis, we knocked down these genes in human mammary cells and in non-transformed MCF10A cells. p53 and PTEN knockdown synergized to activate pro-inflammatory interleukin-6 (IL6)/Stat3/nuclear factor κB signaling. This resulted in generation of highly metastatic epithelial-to-mesenchymal transition-like cancer stem cells resulting in tumors whose gene expression profile mimicked that found in basal/claudin-low molecular subtype within the triple negative breast tumors. Constitutive activation of this loop in transformed cells was dependent on proteolytic degradation of suppressor of cytokine signaling 3 (SOCS3) resulting in low levels of this protein in basal/claudin-low cell lines and primary tumors. In non-transformed cells, transient activation of the IL6 inflammatory loop induced SOCS3 expression leading to pathway inactivation. In transformed cells, enforced expression of SOCS3 or interfering with IL6 pathway via IL6R blockade inhibited tumor growth and metastasis in mouse xenograft models. Furthermore, circulating tumor cells were significantly reduced in tumor-bearing animals when treated with anti-IL6R antibodies. These studies uncover important connections between inflammation and carcinogenesis and suggest that blocking pro-inflammatory cytokines may be utilized as an attractive strategy to target triple negative breast tumors, which currently lacks molecularly targeted therapies.

AB - Somatic mutations or deletions of TP53 and PTEN in ductal carcinoma in situ lesions have been implicated in progression to invasive ductal carcinomas. A recent molecular and mutational analysis of breast cancers revealed that inactivation of tumor suppressors, p53 and PTEN, are strongly associated with triple negative breast cancer. In addition, these tumor suppressors have important roles in regulating self-renewal in normal and malignant stem cells. To investigate their role in breast carcinogenesis, we knocked down these genes in human mammary cells and in non-transformed MCF10A cells. p53 and PTEN knockdown synergized to activate pro-inflammatory interleukin-6 (IL6)/Stat3/nuclear factor κB signaling. This resulted in generation of highly metastatic epithelial-to-mesenchymal transition-like cancer stem cells resulting in tumors whose gene expression profile mimicked that found in basal/claudin-low molecular subtype within the triple negative breast tumors. Constitutive activation of this loop in transformed cells was dependent on proteolytic degradation of suppressor of cytokine signaling 3 (SOCS3) resulting in low levels of this protein in basal/claudin-low cell lines and primary tumors. In non-transformed cells, transient activation of the IL6 inflammatory loop induced SOCS3 expression leading to pathway inactivation. In transformed cells, enforced expression of SOCS3 or interfering with IL6 pathway via IL6R blockade inhibited tumor growth and metastasis in mouse xenograft models. Furthermore, circulating tumor cells were significantly reduced in tumor-bearing animals when treated with anti-IL6R antibodies. These studies uncover important connections between inflammation and carcinogenesis and suggest that blocking pro-inflammatory cytokines may be utilized as an attractive strategy to target triple negative breast tumors, which currently lacks molecularly targeted therapies.

KW - IL6

KW - PTEN

KW - breast cancer

KW - inflammatory cytokine

KW - p53

KW - triple negative subtype

UR - http://www.scopus.com/inward/record.url?scp=84893771246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893771246&partnerID=8YFLogxK

U2 - 10.1038/onc.2014.4

DO - 10.1038/onc.2014.4

M3 - Article

C2 - 24531711

AN - SCOPUS:84893771246

VL - 34

SP - 671

EP - 680

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 6

ER -